← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 15, 2015Last known activity
Aug 10, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 6 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (15)
- NCT05968768Lead sponsorPhase 2Aug 10, 2023
- NCT05968768Sponsor investigatorPhase 2Aug 10, 2023
- NCT05395741Lead sponsorPhase 1/Phase 2Apr 28, 2022
- NCT05395741Reponsible party - principal investigatorPhase 1/Phase 2Apr 28, 2022
- NCT04943211Lead sponsorPhase 3Apr 1, 2021
- NCT04943211Overall official - principal investigatorPhase 3Apr 1, 2021
- NCT04943224Sponsor investigatorPhase 2Apr 1, 2021
- NCT04943198Overall official - principal investigatorPhase 2Apr 1, 2021
- NCT04943224Lead sponsorPhase 2Apr 1, 2021
- NCT04943224Overall official - principal investigatorPhase 2Apr 1, 2021
- NCT04943198Sponsor investigatorPhase 2Apr 1, 2021
- NCT04943198Lead sponsorPhase 2Apr 1, 2021
- NCT04943211Sponsor investigatorPhase 3Apr 1, 2021
- NCT03676569Overall official - principal investigatorPhase 1Nov 15, 2015
- NCT03676569CollaboratorPhase 1Nov 15, 2015
Details
- Last known activity
- Aug 10, 2023